Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.
Location: France, Ile-de-France
Employees: 11-50
Total raised: $97.39M
Founded date: 2016
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 01.02.2024 | - | $5.3M | - |
| 25.03.2019 | - | $50.92M | - |
| 04.05.2017 | Series A | $41.18M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 01.02.2024 | France-based Vivet Therapeutics raises EUR 4.9 million in fu... | Paris, France-based clinical-stage biotech company developing novel and long-lasting gene therapies ... | vcbay.news... |
| 01.02.2024 | Vivet Therapeutics Receives EUR 4.9M Financing | Vivet Therapeutics, a Paris, France-based clinical stage biotech company developing novel and long-l... | finsmes.co... |
| 12.01.2022 | VTX-801 Receives U.S. FDA Fast Track Designation for the Tre... | Paris, France and New York, NY, August 12, 2021 – Vivet Therapeutics (“Vivet”), a clinical-stage bio... | healthcap.... |
| 13.04.2021 | Vivet Therapeutics, participada por Ysios Capital y Columbus... | 13/04/2021 Nota de prensa MIRUM PHARMACEUTICALS Y VIVET THERAPEUTICS FIRMAN UN ACUERDO EXCLUSIVO D... | webcapital... |
| 13.04.2021 | Vivet Therapeutics, participated by Ysios Capital and Columb... | 13/04/2021 Press release MIRUM PHARMACEUTICALS AND VIVET THERAPEUTICS ENTER INTO EXCLUSIVE WORLDWI... | webcapital... |
| 25.03.2019 | Vivet Therapeutics Receives €45M Investment from Pfizer | Vivet Therapeutics, a Paris, France-based gene therapy biotech company dedicated to developing treat... | finsmes.co... |
| 20.03.2019 | Pfizer adquiere una participación del 15% en Vivet Therapeut... | 20/03/2019 Nota de prensa PFIZER ADQUIERE UNA PARTICIPACIÓN DEL 15% EN VIVET THERAPEUTICS, PARTICI... | webcapital... |
| 04.05.2017 | Term Sheet — Thursday, May 4 | ET CETERA New money: Heap, an analytics software company, has raised $27 million in Series B funding... | fortune.co... |
| 04.05.2017 | Vivet Therapeutics Raises €37.5M in Series A Financing | Vivet Therapeutics, a Paris, France-based biotechnology company developing novel gene therapies for ... | finsmes.co... |
| - | Pfizer secures exclusive option to acquire gene therapy comp... | Pfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease ... | healthcap.... |
Show more